Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal
Молекулярная медицина, 2013, № 6

Molecular Medicine

2013, No. 6

Published materials: 10.

See the journal’s author guidelines for manuscript submission and formatting requirements.

Submit an article

Table of contents

Articles

Research article2013

MOLECULAR CHARACTERIZATION OF UTERINE LEIOMYOMA ACCORDINGTO EXPRESSION OF GENES OF STEROID RECEPTORS, STS, SULT AND PTEN

Leiomyoma is one of the most common benign tumors of the female reproductive system. As this pathology in most cases is hormone dependent, we determined the level of gene expression of steroid receptors ERs, PR, estrogen sulfotransferase SULT1E1, STS steroid s…

Details ↗ PDF
Research article2013

EGFR AND KRAS MUTATIONS IMPORTANT FOR NON-SMALL CELL LUNG CANCER TARGET THERAPY

Last successful results in target therapy of cancer were achieved with different tyrosine kinases inhibitors (TKI). Target therapy of non-small cell lung cancer (NSCLC) with EGFR inhibitors gefitinib and erlotinib is effective only in patients with somatic mut…

Details ↗ PDF
Research article2013

THE STUDY OF TOXIC AND ALLERGENIC PROPERTIES OF THE NEW PHARMACEUTICAL COMPOSITIONOF DIINDOLYLMETHANE

Preclinical experimental study of toxic and allergenic properties of new pharmaceutical composition of diindolylmethane was carried on in various doses. It was established that tested drug refers to toxicity class V (almost non-toxic pharmaceutical substance) …

Details ↗ PDF
Research article2013

RANK/RANKL/OPG SYSTEM IN BONE METASTASES AND PRIMARY BONE TUMORS

RANK/RANKL/OPG system – is a key element in bone homeostasis. In this review we depict the basic principles of functioning of this system and known genetical anomalies affecting its components. Also we describe a number of pathological states associated with d…

Details ↗ PDF
Research article2013

VASCULAR ENDOTHELIAL GROWTH FACTOR AND COMPONENTS OF PLASMINOGEN ACTIVATION SYSTEMIN ENDOMETRIAL CANCER: CLINICO-MORPHOLOGICAL CORRELATIONS

The content of VEGF and some components of plasminogen activation system (uPA, PAI-1 and tPA) was determined by enzyme immunoassay methods in the tumors from 121 endometrial cancer patients and in 18 samples of endometrial hyperplasia. Concentrations of uPA an…

Details ↗ PDF

Article search and quick navigation

Navigation